People receiving hormone therapy during gender transition had an elevated risk for cardiovascular events, such as strokes, blood clots and heart attacks. Findings underscore the importance of counseling and close monitoring of transgender patients receiving hormone therapy.
In the current issue of Cardiovascular Innovations and Applications, Juan R. Vilaro from the Division of Cardiovascular Medicine, University of Florida, Gainesville, Fla., USA considers stable ischemic heart disease in the older adult.
In the current issue of Cardiovascular Innovations and Applications, Cody Schwartz and David Winchester from the Malcom Randall VAMC, Gainesville, Fla., USA consider diabetes mellitus and stable ischemic heart disease.
In the current issue of Cardiovascular Innovations and Applications, C. Richard Conti from the University of Florida Medical School, Gainesville, Fla., USA considers epidemiology, pathophysiology, and therapeutic targets in stable ischemic heart disease.
In the current issue of Cardiovascular Innovations and Applications, Radmila Lyubarova, Joshua Schulman-Marcus and William E. Boden from the Division of Cardiology, Department of Medicine, Albany Medical Center, Albany, N.Y., USA and VA New England Healthcare System, Boston, Mass., USA, consider contemporary management of patients with stable ischemic heart disease.
The journal Cardiovascular Innovations and Applications (CVIA) has just published a new issue, Volume 3 Issue 3. This is a Special Issue on Stable Ischemic Heart Disease.
Scientists have discovered new ways in which the body regulates blood clots, in a discovery which could one day lead to the development of better treatments that could help prevent and treat conditions including heart diseases, stroke and vascular dementia.
Susceptibility to obesity, insulin resistance and other cardio-metabolic traits may also be dependent on a person's sex. An international research team studied sex differences and sex-specific interaction with the genetic background in cardio-metabolic phenotypes. The researchers discovered, among other things, a sex-specific obesity locus of the Lypla1 gene, which is associated with human obesity. The results of the study have now been published in Cell Metabolism.
Active, middle-aged men able to complete more than 40 push-ups had a significantly lower risk of cardiovascular disease (CVD) outcomes -- including diagnoses of coronary artery disease and major events such as heart failure -- during 10 years of follow-up compared with those who were able to do less than 10 push-ups during the baseline exam.
Setbacks in drug trials aiming to raise HDL have led researchers to reassess the particle's effects on heart health. A study in the Journal of Lipid Research combining proteomics and mouse genetics may help researchers understand researchers understand the proteins in the particle, how they get there and how they determine HDL function.